1. Home
  2. SCWO vs POM Comparison

SCWO vs POM Comparison

Compare SCWO & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 374Water Inc.

SCWO

374Water Inc.

HOLD

Current Price

$2.87

Market Cap

45.2M

Sector

Utilities

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.24

Market Cap

47.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
SCWO
POM
Founded
2021
2015
Country
United States
China
Employees
N/A
N/A
Industry
Environmental Services
Other Specialty Stores
Sector
Utilities
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
47.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
SCWO
POM
Price
$2.87
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.9K
1.2M
Earning Date
05-14-2026
05-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$215,037.00
N/A
Revenue This Year
$5,945.19
N/A
Revenue Next Year
$106.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.19
52 Week High
$3.60
$6.43

Technical Indicators

Market Signals
Indicator
SCWO
POM
Relative Strength Index (RSI) 51.88 38.44
Support Level $2.35 $0.20
Resistance Level $2.97 $0.27
Average True Range (ATR) 0.32 0.04
MACD -0.01 -0.01
Stochastic Oscillator 37.17 7.23

Price Performance

Historical Comparison
SCWO
POM

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: